These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3254185)

  • 1. Cyclosporine A versus cyclosporine G: a comparative study of survival, hepatotoxicity, nephrotoxicity, and splenic atrophy in BALB/c mice.
    Masri MA; Naiem M; Pingle S; Daar AS
    Transpl Int; 1988 Apr; 1(1):13-8. PubMed ID: 3254185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A.
    Burdmann EA; Andoh TF; Rosen S; Lindsley J; Munar MY; Elzinga LW; Bennett WM
    Kidney Int; 1994 Mar; 45(3):684-91. PubMed ID: 8196271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative toxicological study of cyclosporine and Nva2-cyclosporine in Sprague-Dawley rats.
    Duncan JI; Thomson AW; Simpson JG; Davidson RJ; Whiting PH
    Transplantation; 1986 Oct; 42(4):395-9. PubMed ID: 3765053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and tolerability of cyclosporine G in human kidney transplant recipients.
    Huser B; Thiel G; Oberholzer M; Beveridge T; Bianchi L; Mihatsch MJ; Landmann J
    Transplantation; 1992 Jul; 54(1):65-9. PubMed ID: 1631947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of less chronic nephrotoxicity by cyclosporine G than cyclosporine A in a low-salt rat model.
    Burdmann EA; Rosen S; Lindsley J; Elzinga L; Andoh T; Bennett WM
    Transplantation; 1993 May; 55(5):963-6. PubMed ID: 8497907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of cyclosporine A and Nva2-cyclosporine (cyclosporine G) in a rat renal allograft model.
    Grant D; Zhong R; Stiller C; Wallace C; Keown P; Duff J
    Transplantation; 1987 Jul; 44(1):9-12. PubMed ID: 3299927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that cyclosporine G is less deleterious to rat bone in vivo than cyclosporine A.
    Stein B; Takizawa M; Schlosberg M; Movsowitz C; Fallon M; Berlin JA; Epstein S
    Transplantation; 1992 Mar; 53(3):628-32. PubMed ID: 1549857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deleterious effect of cyclosporins on the ischemic kidney in the rat and the protection by the calcium antagonist verapamil.
    Ar'Rajab A; Dawidson IJ; Harris RB; Mileski WJ; Sentementes JT
    J Am Soc Nephrol; 1994 Jul; 5(1):93-101. PubMed ID: 7948788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotoxicity of cyclosporine A and cyclosporine G in a rat model.
    Tejani A; Lancman I; Pomrantz A; Khawar M; Chen C
    Transplantation; 1988 Jan; 45(1):184-7. PubMed ID: 3336915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro.
    Rayat G; Yatscoff R; Silverman R; McKenna R
    Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine analogues.
    Jeffery JR
    Clin Biochem; 1991 Feb; 24(1):15-21. PubMed ID: 2060128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicity of rapamycin--a comparative and combination study with cyclosporine at immunotherapeutic dosage in the rat.
    Whiting PH; Woo J; Adam BJ; Hasan NU; Davidson RJ; Thomson AW
    Transplantation; 1991 Aug; 52(2):203-8. PubMed ID: 1871790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of Nva2-cyclosporine in primate cardiac transplantation.
    Ogunnaike HO; Starkey TD; Baldwin JC; Porter KA; Billingham ME; Jamieson SW
    Transplantation; 1987 Jan; 43(1):13-7. PubMed ID: 3541313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine G and D in experimental autoimmune uveoretinitis in the rat.
    Kawashima H; Mochizuki M; Okumura A; Fujino Y; Tange T; Horiuchi D; Higashihara E; Kaku H; Inaba G
    Jpn J Ophthalmol; 1989; 33(4):425-40. PubMed ID: 2625778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of low and high density lipoproteins on renal cyclosporine A and cyclosporine G disposition in the isolated perfused rat kidney.
    Strong ML; Ueda CT
    Pharm Res; 1997 Oct; 14(10):1466-71. PubMed ID: 9358563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the hepatic drug-metabolizing enzyme-inducer phenobarbitone on cyclosporine nephrotoxicity and hepatotoxicity in renal-allografted rats.
    Duncan JI; Heys SD; Thomson AW; Simpson JG; Whiting PH
    Transplantation; 1988 Apr; 45(4):693-7. PubMed ID: 3282350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cytokine production by cyclosporine A and G.
    McKenna RM; Szturm K; Jeffery JR; Rush DN
    Transplantation; 1989 Feb; 47(2):343-8. PubMed ID: 2493179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of cyclosporin A, cyclosporin G, and the novel cyclosporin derivative IMM 125 in isolated glomeruli and cultured rat mesangial cells: a morphometric analysis.
    Potier M; Wolf A; Cambar J
    Nephrol Dial Transplant; 1998 Jun; 13(6):1406-11. PubMed ID: 9641169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.
    Gruber SA; Gallichio M; Rosano TG; Kaplan SS; Hughes SE; Urbauer DL; Singh TP; Lempert N; Conti DJ; Stein DS; Drusano G
    J Clin Pharmacol; 1997 Jul; 37(7):575-86. PubMed ID: 9243350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotection with pituitary adenylate cyclase-activating polypeptide in cyclosporine A-induced nephrotoxicity.
    Khan AM; Li M; Brant E; Maderdrut JL; Majid DS; Simon EE; Batuman V
    J Investig Med; 2011 Jun; 59(5):793-802. PubMed ID: 21383633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.